<DOC>
	<DOCNO>NCT02311530</DOCNO>
	<brief_summary>The study conduct open-label , balance , randomize , two-treatment , two-period , two-sequence , single-dose , crossover , bioequivalence study compare felodipine extend release tablet USP 10 mg ( contain felodipine 10 mg ) manufacture OHM Laboratories Inc. , NJ , 08901 PLENDILÂ® extend release tablet 10 mg ( contain felodipine 10 mg ) manufacture Merck &amp; Co. Inc. Whitehouse Station , NJ 08889 USA AstraZeneca LP Wilmington , DE 19850 healthy , adult , male , human subject feed condition .</brief_summary>
	<brief_title>Bioequivalence Study Felodipine ER Tablets 10 mg Under Fed Conditions</brief_title>
	<detailed_description>All subject subject breath test alcohol test drug abuse ( opioids cannabinoids ) prior admission period . Only subject negative result test precede activity . Following overnight fast least 10 hour , high-fat highcalorie breakfast serve study subject . Thirty minute start breakfast , single oral dose felodipine extend release tablet 10 mg either test reference formulation administer period study , along 240 mL drink water ambient temperature low light condition supervision train study personnel . During course study , safety parameter assess vital sign , clinical examination , medical history clinical laboratory safety test ( hematology , biochemical parameter , serology urine analysis ) baseline . Adverse event monitoring do throughout study . Laboratory parameter hematology biochemistry ( except blood glucose cholesterol ) repeat end study .</detailed_description>
	<mesh_term>Felodipine</mesh_term>
	<criteria>Volunteers meet follow criterion include study Were age range 1845 year . Were neither overweight underweight height per Life Insurance Corporation India height/weight chart nonmedical case . Had voluntarily give write informed consent participate study . Were normal health determine medical history physical examination subject perform within 21 day prior commencement study . Had nonvegetarian diet habit . History known hypersensitivity Felodipine , related drug drug Individuals systolic blood pressure &lt; 100 mmHg &gt; 140mmHg diastolic blood pressure &lt; 60 mmHg &gt; 90 mmHg , time admission period I . History chronic headache , dizziness syncope . History peripheral edema . History grapefruit juice / grapefruit supplement intake past 48 hour . Any evidence organ dysfunction clinically significant deviation normal , physical clinical determination Presence disease marker HIV 1 2 , Hepatitis B C viruses syphilis infection . Presence value significantly different normal reference range and/or judge clinically significant hemoglobin , total white blood cell count , differential WBC count platelet count . Positive urinary screen test drug abuse ( opiates cannabinoids ) . Presence value significantly different normal reference range and/or judge clinically significant serum creatinine , blood urea nitrogen , serum aspartate aminotransferase ( AST ) , serum alanine aminotransferase ( ALT ) , serum alkaline phosphatase , serum bilirubin , plasma glucose serum cholesterol . Clinically abnormal chemical microscopic examination urine define presence RBC , WBC ( &gt; 4/HPF ) , glucose ( positive ) protein ( positive ) . Clinically abnormal ECG Chest Xray . History serious gastrointestinal , hepatic , renal , cardiovascular , pulmonary , neurological haematological disease , diabetes glaucoma . History psychiatric illness might impair ability provide write informed consent . Regular smoker smoke 10 cigarette daily difficulty abstain smoke duration study period . History drug dependence excessive alcohol intake habitual basis 2 unit alcoholic beverage per day ( 1 unit equivalent half pint beer 1 glass wine 1 measure spirit ) difficulty abstain duration study period . Use enzyme modifying drug within 30 day prior Day 1 study . Participation clinical trial within 12 week precede Day 1 study . Subjects , completion study , would donate and/or lose 350 mL blood past 3 month .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2014</verification_date>
</DOC>